ArticleWorld journal of urology2026
Flexible ureterorenoscopy and lithotripsy with pulsed thulium: YAG laser: a multicenter retrospective study.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn vivo data on volumetric laser efficiency and clinical outcomes of the p-Tm: YAG laser from large multicenter cohorts remain limited. The present study aimed to evaluate the real-world in vivo volumetric ablation efficiency of the p-Tm: YAG laser during flexible ureterorenoscopy (FURS), with secondary assessment of clinical outcomes and safety in a multicenter cohort.
methodsWe conducted a retrospective multicenter cohort study including adult patients (≥ 18 years) who underwent p-Tm: YAG-based FURS for ureteral and/or renal calculi at three tertiary referral centers between 2023 and 2025. Preoperative stone volume was quantified using manual three-dimensional CT segmentation. Laser-on time (LOT), total delivered energy, and laser settings were prospectively recorded. Volumetric ablation speed (mm³/s) and energy consumption (J/mm³) were calculated using standardized definitions based on segmented pre- and postoperative stone volumes in patients with postoperative non-contrast CT (NCCT). Stone-free rate (SFR) was assessed 1-3 months postoperatively using NCCT and classified as Grade A (no residual fragments), Grade B (residual fragments ≤ 2 mm), and Grade C (residual fragments ≤ 4 mm). In patients without postoperative NCCT, SFR was assessed by intraoperative endoscopic evaluation and analyzed separately.
resultsOf 222 screened patients, 167 met the inclusion criteria. Median preoperative stone volume was 987 mm³ (IQR 329-3,124), and 47% of patients presented with multiple/complex stones. Median LOT was 21.4 min, and median total delivered energy was 12 kJ. In the 108 patients with paired volumetric data and postoperative NCCT, median ablation speed was 0.55 mm³/s (IQR 0.30-0.95), and median energy consumption was 13 J/mm³ (IQR 8-23). In this NCCT subgroup, SFR were 47%, 59%, and 66% for Grade A, B, and C, respectively. Among the 59 patients assessed endoscopically only, complete stone clearance was visually assessed in 20 patients (34%). Overall, 45 patients (27%) required additional stone-related treatment. Complications were uncommon, with 4.8% Clavien-Dindo grade I-II events and 0.6% grade III events; no grade IV-V complications were observed.
conclusionIn this multicenter real-world cohort, p-Tm: YAG laser lithotripsy showed measurable volumetric efficiency and was associated with acceptable stone clearance and a favorable safety profile during FURS. These findings support the clinical feasibility of this technology in routine endourological practice; however, prospective comparative studies are warranted to further define its relative performance compared with established laser platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.